Efficacy of dietary prebiotic supplementation versus maltodextrin on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes

Monash University0 个研究点目标入组 40 人开始时间: 2013年2月4日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Individuals diagnosed with prediabetes (Impaired Fasting Glucose or Impaired Glucose Tolerance) within the previous 12 months. Diagnosis will have been made at each individual’s local GP clinic after undertaking an Oral Glucose Tolerance Test. Prediabetes was defined as a fasting plasma glucose concentration greater than or equal to 6.1 and less than 7.0 mmol/L followed by a 2-hour post glucose load glucose concentration less than 7.8 mmol/L, or a fasting plasma glucose less than 7.0 mmol/L followed by a 2-hour post glucose load glucose concentration greater than or equal to 7.8 and less than 11.1 mmol/L.

•Individuals previously diagnosed with type 1, type 2 diabetes or impaired renal function, individuals with any gastrointestinal pathology (coeliac disease, inflammatory bowel disease), cigarette smokers, pregnant women, individuals already taking antibiotics or dietary prebiotic or probiotic nutritional supplements, individuals taking aspirin or Vitamin B, individuals who have made major dietary or lifestyle changes in the previous three months, individuals who are unwilling to provide blood, urine and stool samples or are unable to attend their local pathology collection centre.

发起方